The Potential for Harnessing the Microbiome for Treating Neurologic Disease

Time: 11:30 am
day: Conference Day 1 Track A AM 1


  • Outlining how the gut microbiota may affect neurologic diseases by modulating immune responses or by secreting neuroactive substances
  • Navigating the application of microbiome therapeutics by addressing disease-specific treatment needs, and may differ between multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer’s disease
  • Exploring important strain-specific activities within the gut microbiome may be the key to effective therapy